To determine the impact that the presence or absence of macrophages, systemically, has on NR2F1 expression, we treated tumor-bearing mice (SM model) with control liposomes or clodronate liposomes to systemically deplete them of macrophages56. The gene discussed is NR2F1; the disease is neoplasm.